Amgen To Buy Ireland's Horizon Therapeutics For $28B
Biotechnology company Amgen, led by Sullivan & Cromwell LLP and William Fry LLP, has agreed to acquire Horizon Therapeutics, an Ireland-based drugmaker that is being advised by Cooley LLP and Matheson LLP,...To view the full article, register now.
Already a subscriber? Click here to view full article